Reduction of ringing artifacts in the arterial phase of gadoxetic acid-enhanced dynamic MR imaging

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Purpose: We assessed what MR imaging parameters affected ringing artifacts during the arterial phase of gadoxetic acid-enhanced dynamic magnetic resonance (MR) imaging. Materials and Methods: We tested various parameters, including imaging matrices, choice of either sequential or elliptical centric phase-encoding scheme, scanning time, and contrast injection rate using new simulation software on a personal computer and visually evaluated clinical MR images retrospectively using a 4-point scale to assess ringing artifacts. Results: The simulation study revealed that square matrices, short scanning time, slow injection rate, and sequential view ordering effectively reduced ringing artifacts, findings confirmed in clinical practice using gadoxetic acid-enhanced MR imaging. Significantly fewer artifacts resulted using a slow injection rate (P<0.05) and using square matrices in the arterial (P<0.05), portal (P<0.01), and hepatocytic (P<0.05) phases. Conclusion: Choice of square matrix, slower injection rate, shorter scanning time, and sequential view ordering could reduce ringing artifacts.

Original languageEnglish
Pages (from-to)91-97
Number of pages7
JournalMagnetic Resonance in Medical Sciences
Volume11
Issue number2
DOIs
Publication statusPublished - 2012

Fingerprint

Artifacts
Magnetic Resonance Imaging
Injections
Microcomputers
Magnetic Resonance Spectroscopy
Software
gadolinium ethoxybenzyl DTPA

Keywords

  • Dynamic MR imaging
  • Gadoxetic acid
  • Ringing artifact

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

@article{581c56e12fa3488d9a13f67d1bc6c77a,
title = "Reduction of ringing artifacts in the arterial phase of gadoxetic acid-enhanced dynamic MR imaging",
abstract = "Purpose: We assessed what MR imaging parameters affected ringing artifacts during the arterial phase of gadoxetic acid-enhanced dynamic magnetic resonance (MR) imaging. Materials and Methods: We tested various parameters, including imaging matrices, choice of either sequential or elliptical centric phase-encoding scheme, scanning time, and contrast injection rate using new simulation software on a personal computer and visually evaluated clinical MR images retrospectively using a 4-point scale to assess ringing artifacts. Results: The simulation study revealed that square matrices, short scanning time, slow injection rate, and sequential view ordering effectively reduced ringing artifacts, findings confirmed in clinical practice using gadoxetic acid-enhanced MR imaging. Significantly fewer artifacts resulted using a slow injection rate (P<0.05) and using square matrices in the arterial (P<0.05), portal (P<0.01), and hepatocytic (P<0.05) phases. Conclusion: Choice of square matrix, slower injection rate, shorter scanning time, and sequential view ordering could reduce ringing artifacts.",
keywords = "Dynamic MR imaging, Gadoxetic acid, Ringing artifact",
author = "Akihiro Tanimoto and Nobuya Higuchi and Akihisa Ueno",
year = "2012",
doi = "10.2463/mrms.11.91",
language = "English",
volume = "11",
pages = "91--97",
journal = "Magnetic Resonance in Medical Sciences",
issn = "1347-3182",
publisher = "Japan Society of Magnetic Resonance in Medicine",
number = "2",

}

TY - JOUR

T1 - Reduction of ringing artifacts in the arterial phase of gadoxetic acid-enhanced dynamic MR imaging

AU - Tanimoto, Akihiro

AU - Higuchi, Nobuya

AU - Ueno, Akihisa

PY - 2012

Y1 - 2012

N2 - Purpose: We assessed what MR imaging parameters affected ringing artifacts during the arterial phase of gadoxetic acid-enhanced dynamic magnetic resonance (MR) imaging. Materials and Methods: We tested various parameters, including imaging matrices, choice of either sequential or elliptical centric phase-encoding scheme, scanning time, and contrast injection rate using new simulation software on a personal computer and visually evaluated clinical MR images retrospectively using a 4-point scale to assess ringing artifacts. Results: The simulation study revealed that square matrices, short scanning time, slow injection rate, and sequential view ordering effectively reduced ringing artifacts, findings confirmed in clinical practice using gadoxetic acid-enhanced MR imaging. Significantly fewer artifacts resulted using a slow injection rate (P<0.05) and using square matrices in the arterial (P<0.05), portal (P<0.01), and hepatocytic (P<0.05) phases. Conclusion: Choice of square matrix, slower injection rate, shorter scanning time, and sequential view ordering could reduce ringing artifacts.

AB - Purpose: We assessed what MR imaging parameters affected ringing artifacts during the arterial phase of gadoxetic acid-enhanced dynamic magnetic resonance (MR) imaging. Materials and Methods: We tested various parameters, including imaging matrices, choice of either sequential or elliptical centric phase-encoding scheme, scanning time, and contrast injection rate using new simulation software on a personal computer and visually evaluated clinical MR images retrospectively using a 4-point scale to assess ringing artifacts. Results: The simulation study revealed that square matrices, short scanning time, slow injection rate, and sequential view ordering effectively reduced ringing artifacts, findings confirmed in clinical practice using gadoxetic acid-enhanced MR imaging. Significantly fewer artifacts resulted using a slow injection rate (P<0.05) and using square matrices in the arterial (P<0.05), portal (P<0.01), and hepatocytic (P<0.05) phases. Conclusion: Choice of square matrix, slower injection rate, shorter scanning time, and sequential view ordering could reduce ringing artifacts.

KW - Dynamic MR imaging

KW - Gadoxetic acid

KW - Ringing artifact

UR - http://www.scopus.com/inward/record.url?scp=84863850651&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863850651&partnerID=8YFLogxK

U2 - 10.2463/mrms.11.91

DO - 10.2463/mrms.11.91

M3 - Article

VL - 11

SP - 91

EP - 97

JO - Magnetic Resonance in Medical Sciences

JF - Magnetic Resonance in Medical Sciences

SN - 1347-3182

IS - 2

ER -